Clinical Trials Browser

Endometrial Neoplasms × irofulven × Clear all

NCT00005031 2013-05-27

Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer

Phase 2 Completed

Endometrial Neoplasms